Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • In Brief
  • Published:

Tumour dormancy

A perivascular niche can promote dormancy

Nature Reviews Cancer volume 13, page 441 (2013)Cite this article

Subjects

A substantial proportion of patients with breast cancer develop distant metastases after years and sometimes even decades of latency. Mina Bissell and colleagues have found that the expression of thrombospondin 1 by vascular cells that are part of a stable vasculature promotes breast cancer cell quiescence. However, in sprouting neovasculature, this effect is lost and breast cancer cell growth is promoted through the expression of transforming growth factor β1 and periostin by endothelial tip cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Ghajar, C. M. et al. The perivascular niche regulates breast tumour dormancy. Nature Cell Biol. 2 Jun 2013 (10.1038/ncb2767)

Download references

Authors
  1. Nicola McCarthy
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

McCarthy, N. A perivascular niche can promote dormancy. Nat Rev Cancer 13, 441 (2013). https://doi.org/10.1038/nrc3561

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nrc3561

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer